A new study suggests that almost half of people stopping GLP-1 weight-loss drugs may keep the weight off. However, many of these people continued other forms of treatment after stopping GLP-1 drugs.

Long-term lithium therapy remains the most effective maintenance treatment for bipolar disorder, yet it poses a significant risk of progressive renal impairment in a subset of patients. Early ...

Rapid genetic test for IVF identifies FSHR variant in 60 minutes, guiding IVF hormone selection and improving in vitro fertilization success.

Methylone is a drug that is thought to enhance neuroplasticity. In a recent clinical trial, this drug led to clinically meaningful improvement in symptoms of PTSD.

A randomized phase 2 maintenance strategy with cabozantinib 60 mg daily for up to 2 years failed to improve 4-month PFS versus placebo in high-grade uterine sarcomas. Median PFS was identical at 3.7 ...

BACKGROUND: Premature atrial contractions (PACs) are independently associated with atrial fibrillation, stroke, and heart failure, yet no pharmacological therapy is approved for PAC suppression.

Led by researchers at NDORMS as part of the Data Analysis and Real World Interrogation Network (DARWIN EU) initiative, a new ...

IFS is believed to be a useful treatment for PTSD. A new study provides the first research-based evidence of its efficacy.

NYU Langone’s decision comes amid Trump administration threats to cut funding to providers who treat trans youth NYU Langone Health, one of New York City’s major hospital networks, announced this week ...

COLORADO SPRINGS, Colo. (KRDO) - For the volunteers with Richards Rubbish Roundup, their cleanup on Tuesday afternoon is anything but random. "Some of them, their favorite thing to do, is see how many ...

Tottenham have been urged to 'change the culture' at the club by axing captain Cristian Romero. The defender has three years remaining on his deal but has come under fire for his ill discipline once ...

NEWARK, Del., Jan. 29, 2026 /PRNewswire/ -- Avobis Bio LLC, a clinical stage company developing implantable cell therapies, announced that expanded primary analysis results from the STOMP2 trial were ...